Justin P O Lindemann

Pharmacodynamics of Camizestrant Behandeling in Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal...

Camizestrant, a next-generation oral SERD, versus fulvestrant in post-menopausal women with oestrogen receptor-positi...

Farmacodynamische vergelijking van CDK4/6-remmers bij mammacarcinoom: window-of-opportunity

Proliferatie en AKT-activiteit na capivasertib bij mammacarcinoom